MARIE BRUUN – DIFFERENTIAL DIAGNOSTICS OF NEURODEGENERATIVE DISEASES MD. Her PhD project explores the potential of and validates the PredictND tool, a data-driven diagnostic decision support system designed to assist clinicians in differential diagnostics of dementia diseases. She is also studying the properties of quantitative measurements of motor signs as diagnostic or prognostic biomarkers.
ANE NØRGAARD CHRISTENSEN – USE OF PSYCHOTROPIC DRUGS IN PATIENTS WITH DEMENTIA
MD. Using nationwide registry data, her PhD project focuses on the use of antipsychotics and other psychotropic drugs in patients with dementia and investigates the mortality risk associated with the use of psychotropic drugs. The aim is to clarify areas of inappropriate medication use and to help prevent the negative consequences hereof.
LE GJERUM – OPTIMISING 18F-FDG-PET IN THE DIAGNOSIS OF DEMENTIA DISORDERSMD. Her PhD project will study the diagnostic impact of 18F-FDG-PET in the dementia diagnosis by evaluating the added value of 18F-FDG-PET in the diagnosis of dementia disorders, and by optimising and evaluating a visual rating scale for cingulate island sign as a biomarker for DLB.
CAMILLA STEEN JENSEN – BIOMARKES AND EXERCISE IN PATIENTS WITH ALZHEIMER’S DISEASEMSc. Her PhD project investigates the beneficial effect of physical exercise on patients with AD measures in CSF. Various aspects of the biochemical parts of AD are being studied, e.g. the diagnostic biomarkers amyloid-beta and tau.
MARIE NATHALIE NICKELSEN HELLEM – HUNTINGTON’ S DISEASE
MD. Her PhD project investigates the role of neuroinflammation in the pathogenesis of HD by examining blood and CSF. The aim is also to look for biomarkers and develop HD stem cells.
JANET JANBEK – ROLE OF INFECTIONS IN DEMENTIA
MSc. Her project will focus on the role of infections in dementia. The project will describe hospital contacts with infections in persons with dementia and compare them to those without dementia and investigate the impact on mortality. Her project will also investigate the role of infections as risk factors, by taking a life-course approach starting from mid-life.
PETER ROOS – CLINICAL AND MOLECULAR ASPECTS OF FTD LINKED TO FTD-3 MD. In the search for early markers and for modifiers of FTD-3, his PhD project examined clinically affected and presymptomatic CHM P2B gene mutation carriers from the Danish FTD-3 family.
CHRISTIAN SANDØE MUSAEUS – EPILEPTIC SEIZURES IN AD
His PhD assesses subclinical epileptiform activity with continuous EEG monitoring using novel ear EEG registration and correlate findings with MRI hippocampal blood flow assessments. Another area of interest is the use of EEG to assist in the diagnosis of Alzheimer’s disease and MCI.
LÆRKE TAUDORF – DEMENTIA AND MORTALITY: A REGISTER-BASED STUDY
MD. Her PhD project reviews time trends of prevalence, incidence and mortality due to dementia from 1996 to 2015, as well as assesses survival after diagnosis. It will also investigate whether certain comorbidities are associated with higher mortality. Finally, the project will review the registered causes of death in individuals with dementia.
LAILA ØKSNEBJERG – ASSISTIVE TECHNOLOGY AND COGNITIVE REHABILITATION
MSc Neuropsychologist. Her project, ReACT, explores assistive technology for people with dementia. As part of the study a cognitive supportive app has been designed and tested through a user-involving innovation process. Methods for implementation and adoption of assistive technology are also investigated, with emphasis on cognitive rehabilitation and self-management of people with dementia.
Read more about Laila Øksnebjergs project ReACT